Skip to main content

JCML clinical trials at UCSF

1 research study open to eligible people

Juvenile Myelomonocytic Leukemia (JMML) is a rare blood cancer in children. UCSF is studying the safety of combining trametinib and azacitidine for newly diagnosed patients. This trial helps understand how these drugs work together in treating JMML.

Showing trials for

Last updated: